Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles

• US 5,989,813 A
• Filed: 06/17/1996
• Issued: 11/23/1999
• Est. Priority Date: 07/13/1995
• Status: Expired due to Term

• Current Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Original Assignee: Molecular Innovations, Inc.
• Inventors: Gerdes, John C.
• Primary Examiner(s): Marschel, Ardin H.
• Assistant Examiner(s): Tung, Joyce
• Application Number:
  US08/664,863
• Time in Patent Office: 1,254 Days
• Field of Search: 435/91.2, 536/24.3, 536/25.3
• US Class Current: 435/6.11
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6804 Nucleic acid analysis using immunogens immunoassay G01N33/53
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 2563/131 the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
• CPC Class Codes: C12Q 2563/149 Particles, e.g. beads
• CPC Class Codes: C12Q 2565/1025 labels being on the same oligonucleotide
• CPC Class Codes: C12Q 2565/113 based on agglutination/precipitation
• CPC Class Codes: C12Q 2565/625 being a nucleic acid test strip device, e.g. dipsticks, strips, tapes, CD plates

Abstract

The invention describes an assay for detecting amplified target nucleic acid sequences with a visual signal. The sensitivity and specificity of the methodology are based on bifunctional target labeling during the amplification step or subsequent hybridization that generates a bifunctional label. The invention may be used, for example, in the screening of amplicon detection for the purpose of more efficiently screening libraries. The invention is also useful to detect nucleic acid sequences indicative of a genetic defect or contagious disease when used with the appropriate primers, as well as detect the existence of nucleic acid amplification.

Claims

1. A method for the detection of amplified target nucleic acid sequences which comprises:

a) denaturing a multiple stranded nucleic acid to produce a single stranded nucleic acid or beginning with a single stranded nucleic acid;

b) amplifying the target nucleic acid sequence with a first hapten derivatized complementary primer and dNTP and a second hapten derivatized complementary primer and dNTP to produce bifinctionally labeled specific target nucleic acid amplicons;

c) contacting dyed microparticles conjugated to a first hapten specific receptor corresponding to said first primer, dyed microparticles conjugated to a second hapten specific receptor corresponding to said second primer and said labeled target nucleic acid sequence wherein an agglutination reaction forms agglutination product of the amplified target nucleic acid; and

d) detecting the resulting agglutination product.

2. The method of claim 1 wherein the primers are derivatized with biotin.

3. The method of claim 1 wherein the primers are derivatized with biotin and digoxigenin.

4. The method of claim 1 wherein the primers are derivatized with biotin and fam.

5. The method of claim 1 wherein the primers are derivatized with biotin, fam or digoxigenin.

6. The method of claim 1 wherein the primers are derivatized with haptens selected from the group consisting of steroids, halogens and 2,4 nitrophenyl.

7. The method of claim 1 wherein the amplification target is any specific nucleic acid sequence.

8. The method of claim 3 wherein the amplification target is nucleic acid sequences for Cytomegalovirus.

9. The method of claim 3 wherein the amplification target is nucleic acid sequences for Human Immunodeficiency Virus.

10. The method of claim 5 wherein the amplification target is nucleic acid sequences for Mycobacterium tuberculosis.

11. The method of claim 1 wherein the target nucleic acid is amplified isothermally.

12. The method of claim 1 wherein the dyed microparticles are covalently bound to hapten specific receptors.

13. The method of claim 1 wherein the amplified target nucleic acid is contacted with receptor bound dyed microparticles during amplification.

14. The method of claim 1 wherein the dyed microparticles are attached to the receptors via adsorption to the microparticles'"'"' surface.

15. The method of claim 12 wherein the bound receptors are streptavidin and anti-digoxigenin antibody.

16. The method of claim 12 wherein the bound receptors are streptavidin and anti-fam antibody.

17. The method claim 1 wherein the microparticles are 0.02-10.0 micrometers in diameter.

18. The method of claim 1 wherein the microparticles are 0.1-1.0 micrometers in diameter.

19. The method of claim 1 wherein the microparticles are composed of an insoluble polymer material.

20. The method of claim 19 wherein the insoluble polymer material is latex.

21. The method of claim 19 wherein the insoluble polymer material is selected from the group consisting of polyethylene, polypropylene, polymethylmethacrylate and polystyrene.

22. The method of claim 1 wherein the microparticles are composed of colloidal gold.

23. The method of claim 1 wherein said agglutination product is detected using a secondary detection probe capable of binding to said microparticles.

24. The method of claim 23 wherein the secondary detection probe is an anti-species antibody.

25. The method of claim 1 wherein said detection is made by a method selected from the group consisting of agglutination observation, lateral flow membrane assay and filtration assay.

26. A kit for the amplification and detection of a target nucleic acid consisting essentially of:

a) target specific hapten labeled primers;

b) thermostable polymerase;

c) dNTPs; and

d) receptor bound dyed microparticles.

27. The kit of claim 26 further consisting of agglutination product detection apparatus.

28. The kit of claim 27 wherein the agglutination product detection apparatus is microporous membrane.

29. The kit of claim 28 wherein the membrane is nitrocellulose or nylon.

30. The kit of claim 29 wherein the membrane has a receptor immobilized thereon.